drugset / Trial / NCT00349128
Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective was to assess the effect of 3-month treatment of low and standard doses of fenofibrate in combination with stable dose of metformin on fasting triglycerides levels in patients with type 2 diabetes and dyslipidemia.
Timeline
- Start
- 2004-01
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fenofibrate | Small molecule | — | — |
| Background | Metformin | Small molecule | — | — |